Literature DB >> 21799514

High Epstein-Barr virus-specific T-cell counts are associated with near-zero likelihood of acute myeloid leukemia relapse after hematopoietic cell transplantation.

M Hoegh-Petersen, S Sy, A Ugarte-Torres, T S Williamson, M Eliasziw, A Mansoor, Y Liu, S Liu, P Podgorny, F Khan, P R Duggan, D A Stewart, J A Russell, J Storek.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21799514     DOI： 10.1038/leu.2011.195

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.

Authors:  Yuhua Ru; Jinjin Zhu; Tiemei Song; Yiyang Ding; Ziling Zhu; Yi Fan; Yang Xu; Aining Sun; Huiying Qiu; Zhengming Jin; Xiaowen Tang; Yue Han; Chengcheng Fu; Suning Chen; Xiao Ma; Feng Chen; Jia Chen; Depei Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-05-16       Impact factor: 6.073

2.  Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation.

Authors:  Mark Bosch; Manveer Dhadda; Mette Hoegh-Petersen; Yiping Liu; Laura M Hagel; Peter Podgorny; Alejandra Ugarte-Torres; Faisal M Khan; Joanne Luider; Iwona Auer-Grzesiak; Adnan Mansoor; James A Russell; Andrew Daly; Douglas A Stewart; David Maloney; Michael Boeckh; Jan Storek
Journal:  Cytotherapy       Date:  2012-09-18       Impact factor: 5.414

3.  CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML.

Authors:  S Ito; P Pophali; Wu CO; E K Koklanaris; J Superata; G A Fahle; R Childs; M Battiwalla; A J Barrett
Journal:  Bone Marrow Transplant       Date:  2013-04-08       Impact factor: 5.483

4.  Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.

Authors:  Pavankumar Reddy Varanasi; Justyna Ogonek; Susanne Luther; Elke Dammann; Michael Stadler; Arnold Ganser; Sylvia Borchers; Lothar Hambach; Eva M Weissinger
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

5.  Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.

Authors:  Yiyang Ding; Yuhua Ru; Tiemei Song; Lingchuan Guo; Xiang Zhang; Jinjin Zhu; Caixia Li; Zhengming Jin; Haiwen Huang; Yuqing Tu; Mimi Xu; Yang Xu; Jia Chen; Depei Wu
Journal:  Ann Hematol       Date:  2021-09-04       Impact factor: 3.673

6.  Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes.

Authors:  Yuhua Ru; Xiang Zhang; Tiemei Song; Yiyang Ding; Ziling Zhu; Yi Fan; Yang Xu; Aining Sun; Huiying Qiu; Zhengming Jin; Xiaowen Tang; Yue Han; Zhengzheng Fu; Suning Chen; Xiao Ma; Feng Chen; Jia Chen; Depei Wu
Journal:  Bone Marrow Transplant       Date:  2020-02-17       Impact factor: 5.483

7.  Predicting the Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: The Long and Winding Road toward Validated Immune Biomarkers.

Authors:  A Forcina; M Noviello; M R Carbone; Chiara Bonini; Attilio Bondanza
Journal:  Front Immunol       Date:  2013-03-25       Impact factor: 7.561

Review 8.  Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effects.

Authors:  Shigeo Fuji; Markus Kapp; Hermann Einsele
Journal:  Front Immunol       Date:  2013-10-14       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.